Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAT-CAT: Statin Therapy to Prevent Cancer Associated Venous Thromboembolism
NCT07303816Phase 4Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2026
- Primary completion
- Mar 2031
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in venous thromboembolism (VTE), sponsored by Brigham and Women's Hospital. Started Jun 2026; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT07303816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07303816.